Tigecycline is a broad spectrum glycylcycline antibiotic which was developed to combat infections caused by many leading multi-drug resistant organisms. Tigecycline is structurally related to minocycline, a tetracycline antibiotic; however, it contains a large glycylamido group at the D-9 position. This substitution is thought to be the reason behind its broad spectrum activity. Tigecycline is soluble in water (0.45mg/mL) and DMSO (>3 mg/mL).
This product is considered a dangerous good. Quantities above 1 g may be subject to additional shipping fees. Please contact us for specific questions.
CAS Number
220620-09-7
Molecular Formula
C29H39N5O8
Molecular Weight
585.65
Mechanism of Action
Tigecycline inhibits protein synthesis by binding to the A site of the 30S ribosomal subunit.
Storage Conditions
-20°C
Tariff Code
2941.30.0000
Spectrum
Tigecycline has broad spectrum activity against most Gram positive and Gram negative bacteria including multi-drug resistant organisms such as MRSA. Tigecycline has also been found to be effective against carbapenem resistant Enterobacteriaceae or CRE. CRE is a "superbug" which possesses NDM-1 or KPC genes which encode New Delhi Metallo-beta-lacamase or Klebsiella pneumoniae cabapenemase respectively; two enzymes which render nearly all beta-lactam antibiotics useless.
Form
Powder
Appearance
Orange to Orange-Red Colored Powder
Source
Semi-synthetic
Impurity Profile
Bacterial Endotoxin: ≤1.75 EU/mg
Water Content (Karl Fisher)
≤2.0%
Assay
(As Is): 98.0-102.0%
Residue On Ignition
≤0.1%
Heavy Metals
≤10ppm
Residual Solvents
Meets requirements